The 2013 SciBX Summit on Innovation in Drug Discovery and Development brings together key stakeholders from academia, biotech, pharma and the investment community to create a roadmap for solving key translational issues in important emerging areas of drug discovery and development. This year's summit will focus on four areas where recent progress is rapidly changing the translational playing field: non-coding RNAs, chimeric antigen receptor-based cell therapies, new models in neurological diseases and emerging targets in epigenetics.
The Summit itself is the culmination of a months-long process during which the SciBX editorial team convenes working groups of four to eight key opinion leaders for each topic. These teams sketch the landscape for each of the four areas, identify challenges and opportunities — from basic research to regulatory — and draft a roadmap for innovation in each field to help frame the discussion at the actual Summit meeting. Following the Summit, the SciBX team will create a document outlining the conclusions of the Summit participants, with an emphasis on solving key problems in each field.